Hitting the high-value healthcare system target with communication, collaboration and connections

FiercePharma, Bob Mauch and David Senior

Achieving a high-value healthcare system has never been more in focus on the global stage than in the wake of the COVID-19 pandemic that has required vaccines to be developed at unprecedented pace and scale and then efficiently distributed around the world.

For the full article, visit FiercePharma.